CoChat

Incremental cost‐effectiveness of evidence‐based non‐surgical weight loss strategies

Finkelstein, Eric A., Verghese, Naina R. · 2019 · Clinical Obesity
Cited by 38

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Recent medical advancements have led to new modes of treatment for non‐surgical weight loss, including several new medications. Our aim was to conduct an incremental cost‐effectiveness analysis for all commercially available, evidence‐based non‐surgical weight loss interventions for people with excess weight. We identified interventions through a systematic review of randomized controlled trials that reported weight loss 12 months from baseline. We then meta‐analysed the results, sourced costs and performed an incremental cost‐effectiveness analysis from the payer perspective. Cost‐effectiveness was presented in terms of cost per kilogram lost and quality‐adjusted life years (QALY) gained. We further performed sensitivity analyses on costs and duration of benefits, and a probabilistic sensitivity analysis. Ten interventions were identified for inclusion: six pharmaceutical products (Alli, Xenical, Qsymia, Contrave, Belviq and Saxenda), two lifestyle modification programmes (Weight Watchers Meetings and Online), one food replacement and lifestyle programme (Jenny Craig) and one intragastric balloon system (Orbera). At an incremental cost‐effectiveness ratio of $30 071 per additional QALY gained, only Weight Watchers Meetings was cost‐effective. Sensitivity analyses revealed that for the medications to become incrementally cost‐effective, costs would have to decrease by as much as 91%. Results are highly dependent on duration that benefits are maintained. Despite several newly available interventions, Weight Watchers Meetings is currently the only evidence‐based, commercially available, cost‐effective option for non‐surgical weight loss. Other interventions, specifically medications, are more effective but priced too high to be cost‐effective.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cob.12294

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

Metadata

Authors
Finkelstein, E. A., & Verghese, N. R.
Venue
Clinical Obesity
Publisher
Wiley
Published
2019-01-24
Volume
9
Issue
2
Pages
e12294-e12294
ISSN
  • 1758-8103 (ISSN-L)
  • 1758-8111
OpenAlex
W2913406403
Cited by
38
References
17
FWCI
2.09
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.